Thomas Kirk Acquires 25,000 Shares of Myomo (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Thomas Kirk purchased 25,000 shares of the company’s stock in a transaction on Thursday, May 28th. The stock was acquired at an average cost of $0.99 per share, for a total transaction of $24,750.00. Following the completion of the transaction, the director owned 653,863 shares in the company, valued at approximately $647,324.37. This trade represents a 3.98% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Myomo Stock Performance

MYO opened at $1.06 on Wednesday. The stock has a market cap of $40.96 million, a PE ratio of -2.94 and a beta of 1.47. The company has a current ratio of 2.73, a quick ratio of 2.36 and a debt-to-equity ratio of 1.21. Myomo, Inc. has a 1 year low of $0.61 and a 1 year high of $3.08. The stock’s 50 day simple moving average is $0.82 and its 200-day simple moving average is $0.85.

Analyst Upgrades and Downgrades

Separately, Craig Hallum restated a “buy” rating on shares of Myomo in a research report on Tuesday, March 10th. Four research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $7.67.

Institutional Investors Weigh In On Myomo

Large investors have recently modified their holdings of the business. Jefferies Financial Group Inc. bought a new position in shares of Myomo during the fourth quarter worth about $641,000. Jump Financial LLC grew its holdings in shares of Myomo by 42.2% during the second quarter. Jump Financial LLC now owns 87,000 shares of the company’s stock worth $188,000 after buying an additional 25,802 shares in the last quarter. LPL Financial LLC grew its holdings in shares of Myomo by 132.9% during the fourth quarter. LPL Financial LLC now owns 177,000 shares of the company’s stock worth $161,000 after buying an additional 101,000 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Myomo during the second quarter worth about $134,000. Finally, Acadian Asset Management LLC bought a new position in shares of Myomo during the first quarter worth about $114,000. 44.99% of the stock is currently owned by institutional investors.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.